| Fresenius Kabi (Schweiz) AG - Idacio 40 mg/ 0.8 ml, Injektionslösung in Fertigspritze | | 66828 | | 01 | | Idacio 40 mg/ 0.8 ml | | Injektionslösung in Fertigspritze | | L04AB04 | | Adalimumab | | 17.03.2020 | | |
| | Composition | | Lösung: adalimumabum 40 mg, acidum citricum monohydricum, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, mannitolum, polysorbatum 80, natrii chloridum, trinatrii citras dihydricus, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.8 ml. | | Packungsbestandteile | | Solution injectable en seringue prête à l'emploi | | | | | | | | Principe actif | Concentr. | informations additionels |
|---|
| Adalimumab | 40mg / 0.8ml | Lösung |
| | BAG: Principe actif | Concentr. |
|---|
| Adalimumab | 40 mg |
| | | | Agents auxilliaires |
|---|
| Acide Citrique Monohydre | | Disodium Phosphate Dihydrate | | Mannitol | | Sodium Chlorure | | Sodium Dihydrogenophosphate Dihydrate | | Sodium Hydroxide | | Polysorbatum 80 | | Trinatrii Citras Dihydricus |
| |
| |
|
